{"id":7072,"date":"2021-01-20T18:05:24","date_gmt":"2021-01-20T10:05:24","guid":{"rendered":"https:\/\/uatcphi.imsinoexpo.cn\/?p=7072"},"modified":"2021-12-27T13:25:16","modified_gmt":"2021-12-27T05:25:16","slug":"cphi-p-mec-china-gives-a-glimpse-of-the-success-returning-pharma-events-will-deliver-in-2021","status":"publish","type":"post","link":"https:\/\/www.cphi-china.cn\/en\/cphi-p-mec-china-gives-a-glimpse-of-the-success-returning-pharma-events-will-deliver-in-2021\/","title":{"rendered":"CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021"},"content":{"rendered":"\t\t
20.01.2021 18:05<\/em><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t The fully launched MAH and priority review pathways from the NMPA (National Medical Products Administration) is stimulating new demand in China for 2021.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t Amsterdam, 20 January 2021:<\/strong>The recently hosted CPhI \n& P-MEC China 2020 \u2013 organized by Informa Markets and CCCMHPIE and \nco-organized by Shanghai Sinoexpo Informa Markets International \nExhibition Co., Ltd. \u2013 attracted a remarkable 46,157 visits of \nprofessional pharma visitors, including 5,105 international attendees \ntaking part online.<\/p>\n\n <\/p>\n\n The hybrid event has helped stimulate renewed growth and partnerships\n across the pharma supply chain, with the pharma industry looking well \npositioned for 2021. It also provided a welcome glimpse of how returning\n international pharma events will encourage a boom for the global \nindustry in 2021.<\/p>\n\n <\/p>\n\n With 2020 seeing the majority of global pharma events postponed, \nthere was a huge interest in exhibiting, learning and connecting at \nlarge scale event providing covid-secure standards. The ingredients, \nmachinery and manufacturing sectors reported particularly robust \nattendance \u2013 with full implementation of the Marketing Authorization \nHolder (MAH) system, coupled with priority review pathways from the NMPA\n (National Medical Products Administration) driving much new demand.<\/p>\n\n <\/p>\n\n In fact, 2,958 companies from the pharma supply chain attended \u2013 \nincluding Pfizer, Sanofi, Capsugel, Dupont, Merck, BASF, Fosun Pharma, \nHengrui Medicine, Yangtze River Pharmaceutical and Fette \u2013 as well as \nmore than 90 providers of medical supplies for pandemic prevention at \nthe newly launched MSE (Medical Supplies Expo) China.<\/p>\n\n <\/p>\n\n Another key goal of the event was to enhance industry learning, and \nCPhI & P-MEC China hosted more than 80 professional conferences, \nInnovation Galleries and Tours, and even factory visits. Empowering new \npartnering, the 10th Buyers Sourcing Event attracted more than 100 \nbuyers, delivering hundreds of meetings.<\/p>\n\n <\/p>\n\n Finally, to celebrate the 20th anniversary of CPhI China, the \norganizing committee awarded a \u201cCPhI China 20th Anniversary Founding \nExhibitor Award\u201d and \u201cP-MEC China 15th Anniversary Founding Exhibitor \nAward\u201d on the opening day at the CPhI China 20th anniversary reception.<\/p>\n\n <\/p>\n\n For international online attendees, the event teamed up with \nPharmaSources.com to launch the Virtual Expo Connect (VEC), which ran \nfor a full month in December and connected pharma in China with overseas\n customers.<\/p>\n\n <\/p>\n\n The VEC provided access to eight features including the Digital \nShowroom, Online Matchmaking, Hosted Buyer Video Meeting, Exhibitors\u2019 \nTalk, Conference Webcasts, Guided Tours, VR Show, and Onsite Digital \nCenter. Emphasising the global interest in China, especially in a period\n of restricted international travel, 5,105 registered users took part. \nThese included 529 buyers from Europe, America, Southeast Asia, the \nMiddle East, and Africa, who attended a total of 575 trade meetings \nonline.<\/p>\n\n <\/p>\n\n \u201cIt was a tremendously successful event for pharma and an encouraging\n piece of news to start the year with, providing a window into what the \npost-pandemic exhibition environment can return to. 2021 promises to be a\n celebration of the pharma industry with vaccine distribution now \nunderway and we look forward to helping the industry meet both online \nand in person so it can continue its work in discovering and delivering \nvital therapies to patients,\u201d commented Laura Murina, Brand Manager, \nInforma.<\/p>\n\n <\/p>\n\n CPhI & P-MEC China 2021 will return to SNIEC (from Dec. 16 to 18,\n 2021) with a comprehensive online and offline offering \u2013 providing \naccess to vital connections in person and through enhanced digital \npharma platforms.<\/p>\n\n <\/p>\n\n – ENDS –<\/strong><\/p>\n\n <\/p>\n\n <\/p>\n\n Notes to editors<\/i><\/strong><\/p>\n\n <\/p>\n\n About CPhI<\/strong><\/p>\n\n <\/p>\n\n CPhI drives growth and innovation at every step of the global \npharmaceutical supply chain from drug discovery to finished dosage. \nThrough exhibitions, conferences and online communities, CPhI brings \ntogether more than 100,000 pharmaceutical professionals each year to \nnetwork, identify business opportunities and expand the global market. \nCPhI hosts events in Europe, Korea, China, India, Japan, South East \nAsia, North America, and the Middle East and Africa. Co-locating with \nICSE for contract services; P-MEC for machinery, equipment & \ntechnology; InnoPack for pharmaceutical packaging; bioLIVE for \nbiopharma; Finished Dosage Formulation for every aspect of the finished \ndosage supply chain; and NEX for natural extract products, applications \nand solutions. CPhI provides an online buyer and supplier directory at \nCPhI-Online.com.<\/p>\n\n <\/p>\n\n For more information visit https:\/\/www.cphi.com<\/a><\/p>\n\n <\/p>\n\n About Informa Markets<\/strong><\/p>\n\n <\/p>\n\n Informa Markets creates platforms for industries and specialist \nmarkets to trade, innovate and grow. Our portfolio is comprised of more \nthan 550 international B2B events and brands in markets including \nHealthcare & Pharmaceuticals, Infrastructure, Construction & \nReal Estate, Fashion & Apparel, Hospitality, Food & Beverage, \nand Health & Nutrition, among others. We provide customers and \npartners around the globe with opportunities to engage, experience and \ndo business through face-to-face exhibitions, specialist digital content\n and actionable data solutions. As the world\u2019s leading exhibitions \norganizer, we bring a diverse range of specialist markets to life, \nunlocking opportunities and helping them to thrive 365 days of the year.<\/p>\n\n <\/p>\n\n For more information, please visit www.informamarkets.com<\/a><\/p>\n\n <\/p>\n\n The Informa Markets annual schedule of Pharmaceutical events include:\n CPhI Japan (14-16 April, 2021 at the Big Sight Exhibition Centre \u2013 \nTokyo, Japan); CPhI South East Asia (4-6 August, 2021 at Challenger 2, \nIMPACT, Muang Thong Thani, Thailand); CPhI North America (10 August – 12\n August, 2021 at Pennsylvania Convention Centre \u2013 Philadelphia, USA); \nCPhI Korea (11-13 August 2021), COEX \u2013 Seoul, Korea); CPhI, ICSE, P-MEC,\n FDF, InnoPack Worldwide, BioProduction (31 August \u2013 2 September 2021 at\n Fiera Milano, Milan); CPhI Middle East & Africa (26-28 September, \n2021 at the Riyadh International Convention & Exhibition Center, \nRiyadh, Saudi Arabia); Pharmapack Europe 2021 (13-14 October, 2021 at \nthe Paris Expo, Porte de Versailles \u2013 Paris, France); CPhI & P-MEC \nIndia (24-26 November 2021 at the India Expo Mart, Greater Noida, Delhi \nNCR \u2013 Delhi, India); CPhI & P-MEC China (Dec. 16 to 18, 2021 at \nSNIEC \u2013 Shanghai, China)<\/p>\n\n <\/p>\n\n For media enquiries, please contact:<\/strong><\/p>\n\n Alex Heeley or Abdul Khalifeh<\/p>\n\n De Facto Communications<\/p>\n\n T: +44 (0) 203 735 8168<\/p>\n\n E: a.heeley@defacto.co.uk<\/a> \/ a.khalifeh@defacto.co.uk<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":" The fully launched MAH and priority review pathways from the NMPA (National Medical Products Administration) is stimulating new demand in China for 2021.<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[217],"tags":[],"class_list":["post-7072","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"\n